Antibody- and complement-mediated lysis of HIV-infected cells and inhibition of viral replication
- 1 April 1990
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 30 (4) , 287-293
- https://doi.org/10.1002/jmv.1890300411
Abstract
HIV-1-positive antisera were tested for their ability to lyse HIV-1-infected cells in the presence of active complement. Cytolytic effects caused by sera derived from infected humans were slower than those observed with sera from immunised chimpanzees. Lytic but also negative sera were found among HIV-1-infected asymptomatic men as well as among clinical AIDS cases. Human antisera that lysed infected cells reacted similarly irrespective of whether the complement was heterologous or autologous. Analysis of complement-mediated lysis using defined antisera against recombinant HIV-1 env or core antigens suggested that gp 160/gp 120 and p24 can act as target antigens for an antibody- and complement-mediated cytolysis of infected cells. Complement alone reduced the spread of HIV-1 infection in CD4+ cells and the ability of HIV-1 and HIV-2 to form plaques in CD4-transfected HeLa cells. Co-operative effects of specific antibodies and complement were the most effective in inhibiting HIV infections.Keywords
This publication has 13 references indexed in Scilit:
- Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4Cell, 1988
- Cytopathic effect of human immunodeficiency virus in T4 cells is linked to the last stage of virus infection.Proceedings of the National Academy of Sciences, 1988
- ANTIBODY-DEPENDENT ENHANCEMENT OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INFECTIONThe Lancet, 1988
- Detection of human immunodeficiency virus and other retroviruses in cell culture supernatants by a reverse transcriptase microassayJournal of Virological Methods, 1988
- Serologische AIDS-Diagnostik mit gentechnisch gewonnenen Polypeptiden des menschlichen Immundefizienz-Virus (HIV-1)Journal of Molecular Medicine, 1987
- Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack.Proceedings of the National Academy of Sciences, 1987
- Absence of cytotoxic antibody to human immunodeficiency virus-infected cells in humans and its induction in animals after infection or immunization with purified envelope glycoprotein gp120.Proceedings of the National Academy of Sciences, 1987
- The AIDS-associated retrovirus is not sensitive to lysis or inactivation by human serumVirology, 1986
- Human T-cell leukaemia virus is not lysed by human serumNature, 1984
- Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway.The Journal of Experimental Medicine, 1976